MONTANOVA CAPITAL, LLC bought BNTC
March 26, 2025 · Form 4 insider transaction
MONTANOVA CAPITAL, LLC bought 106,200 shares of Benitec Biopharma Inc. at $13.00 per share, a transaction worth $1.38M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
106,200
Price
$13.00
Total value
$1.38M
InsiderMONTANOVA CAPITAL, LLC
RoleDirector, 10% owner
SecurityCommon stock, par value $0.0001 per share
Transaction codeP: Open-market purchase
Transaction dateMarch 26, 2025
Filing dateMarch 28, 2025
Shares owned after1,066,764
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Notes are included on Exhibit 99.1.; Notes are included on Exhibit 99.1.